Efficacy of quinagolide in the treatment of a patient with hypophyseal resistance to thyroid hormones

De Luis, D.A.; Lahera, M.; Botella, J.I.; Valero, M.A.; Varela, C.

Anales de Medicina Interna 18(5): 259-261

2001


ISSN/ISBN: 0212-7199
PMID: 11496561
Document Number: 531397
The pituitary resistance to thyroid hormones (PRTH) is not very frequent and well-known entity, their treatment it continues being topic of controversy. In this work we have evaluated the quinagolida effectiveness in the treatment of it unites patient with (PRTH). The relationship among thyroid stimulating hormone (TSH) and free triiodothyronine (FT3) it was used as marker of the thyroid resistance and of the response to the treatment. The concentrations of TSH and FT3 were normalized after adding quinagolida to methimazole. These results suggest that the quinagolida could be an useful drug in the treatment of this pathology, next to the classic treatments.

Document emailed within 1 workday
Secure & encrypted payments